Inactive Instrument

Immunosyn Corp Share Price

Stocks

End-of-day quote Other OTC
- ^USD	-

30/-1/30	IMMUNOSYN CORP COM STK USD0.0001 : Immunosyn Announces Proposed Agreements for Distribution of the Biopharmaceutical SF-1019 in Utah	PR
30/-1/30	Immunosyn Corp Com Stk Usd0.0001 : Immunosyn Corporation Files 10-Q	PR
30/-1/30	Immunosyn Corp Com Stk Usd0.0001 : Immunosyn Corporation Announces 2007 Results, Files 10KSB	PR
30/-1/30	Immunosyn Corp Com Stk Usd0.0001 : Immunosyn Releases Wound Healing Photographs From the First Phase 'Proof of Concept Trial' in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019	PR
30/-1/30	Immunosyn Corp Com Stk Usd0.0001 : Douglas A. McClain, Jr. Resumes CFO Duties at Immunosyn	PR

Manager	Title	Age	Since
Stephen D. Ferrone CEO	Chief Executive Officer	75	15/10/2007
Douglas A. McClain DFI	Director of Finance/CFO	51	-

Director	Title	Age	Since
Stephen D. Ferrone BRD	Director/Board Member	75	09/07/2011
Douglas A. McClain CHM	Chairman	51	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
MODERNA, INC.	-0.80%	+14.07%	+705.55%	+96.75%	7.94TCr
REGENERON PHARMACEUTICALS, INC.	-4.54%	-5.75%	+33.40%	-9.86%	7.87TCr
CSL LIMITED	+0.02%	+0.63%	-8.61%	-27.49%	5.95TCr
UCB	-0.89%	+0.19%	+7.92%	+172.79%	4.66TCr
SAMSUNG BIOLOGICS CO.,LTD.	+2.49%	-0.14%	-8.95%	+33.71%	4.65TCr
BIOGEN INC.	+0.48%	+4.39%	+66.48%	-11.30%	3.36TCr
INCYTE CORPORATION	+0.75%	+0.14%	+50.93%	+112.97%	2.51TCr
INNOVENT BIOLOGICS, INC.	+0.21%	-6.64%	+2.83%	+151.63%	2.21TCr
SWEDISH ORPHAN BIOVITRUM AB	+0.73%	-0.95%	+61.19%	+97.04%	1.53TCr
Average	-0.09%	+1.64%	+101.19%	+68.47%	4.52TCr
Weighted average by Cap.	-0.55%	+2.24%	+153.86%	+54.52%

Employees

Sector